PMID- 17143527 OWN - NLM STAT- MEDLINE DCOM- 20070131 LR - 20190606 IS - 1019-6439 (Print) IS - 1019-6439 (Linking) VI - 30 IP - 1 DP - 2007 Jan TI - UV light blocks EGFR signalling in human cancer cell lines. PG - 181-5 AB - UV light excites aromatic residues, causing these to disrupt nearby disulphide bridges. The EGF receptor is rich in aromatic residues near the disulphide bridges. Herein we show that laser-pulsed UV illumination of two different skin-derived cancer cell lines i.e. Cal-39 and A431, which both overexpress the EGF receptor, leads to arrest of the EGFR signaling pathway. The phosphorylation status of the receptor and the level of phosphorylated downstream signaling molecules i.e. AKT and the mitogen activated protein kinases (MAPKs) ERK1 and 2 is detected by Western blotting using phosphospecific antibodies. There was a threshold level, below which the receptor could not be blocked. In addition, illumination caused the cells to upregulate the cyclin-dependent kinase inhibitor p21WAF1, irrespective of the p53 status. Since the EGF receptor is often overexpressed in cancers and other proliferative skin disorders, it might be possible to significantly reduce the proliferative potential of these cells making them good targets for laser-pulsed UV light treatment. FAU - Olsen, B B AU - Olsen BB AD - Institute for Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark. FAU - Neves-Petersen, M T AU - Neves-Petersen MT FAU - Klitgaard, S AU - Klitgaard S FAU - Issinger, O G AU - Issinger OG FAU - Petersen, S B AU - Petersen SB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Greece TA - Int J Oncol JT - International journal of oncology JID - 9306042 RN - EC 2.7.10.1 (ErbB Receptors) SB - IM MH - Cell Line, Tumor MH - Dose-Response Relationship, Radiation MH - ErbB Receptors/*physiology/*radiation effects MH - Humans MH - Lasers MH - Signal Transduction/*radiation effects MH - Skin Neoplasms MH - *Ultraviolet Rays EDAT- 2006/12/05 09:00 MHDA- 2007/02/01 09:00 CRDT- 2006/12/05 09:00 PHST- 2006/12/05 09:00 [pubmed] PHST- 2007/02/01 09:00 [medline] PHST- 2006/12/05 09:00 [entrez] AID - 10.3892/ijo.30.1.181 [doi] PST - ppublish SO - Int J Oncol. 2007 Jan;30(1):181-5. doi: 10.3892/ijo.30.1.181.